More
Dr Zdenko Herceg, Head of the Epigenetics Group at the International Agency for Research on Cancer (IARC), answers questions about the EpiMark project and shares details of some exciting preliminary results, in a new interview to mark Breast Cancer Awareness Month, which occurs in October every year. The EpiMark project is a study of biomarkers in blood and their potential associations with breast cancer risk.
The International Agency for Research on Cancer (IARC) hosted senior personnel of the World Healt...
The results of the recent meeting of the Advisory Group to Recommend Priorities for the IARC Mono...
The biobank of the International Agency for Research on Cancer (IARC) has been granted one of six...